[1] |
Mendes FB, Hissa⁃Elian A, Abreu MA, et al. Review: dermatitis herpetiformis[J]. An Bras Dermatol, 2013,88(4):594⁃599. doi: 10.1590/abd1806⁃4841.20131775.
|
[2] |
Salmi TT, Hervonen K, Kautiainen H, et al. Prevalence and incidence of dermatitis herpetiformis: a 40⁃year prospective study from Finland[J]. Br J Dermatol, 2011,165(2):354⁃359. doi: 10.1111/j.1365⁃2133.2011.10385.x.
|
[3] |
Handa S, Dabas G, De D, et al. A retrospective study of dermatitis herpetiformis from an immunobullous disease clinic in north India[J]. Int J Dermatol, 2018,57(8):959⁃964. doi: 10. 1111/ijd.14029.
|
[4] |
Ohata C, Ishii N, Hamada T, et al. Distinct characteristics in Japanese dermatitis herpetiformis: a review of all 91 Japanese patients over the last 35 years[J]. Clin Dev Immunol, 2012,2012:562168. doi: 10.1155/2012/562168.
|
[5] |
Ohata C, Ishii N, Niizeki H, et al. Unique characteristics in Japanese dermatitis herpetiformis[J]. Br J Dermatol, 2016,174(1):180⁃183. doi: 10.1111/bjd.13965.
|
[6] |
靳培英, 是元甫. 疱疹样皮炎在我国的发病情况及其诊断标准的商榷[J]. 中华皮肤科杂志, 1991,24(4):232⁃234.
|
[7] |
Zhang F, Yang B, Lin Y, et al. Dermatitis herpetiformis in China: a report of 22 cases[J]. J Eur Acad Dermatol Venereol, 2012,26(7):903⁃907. doi: 10.1111/j.1468⁃3083.2011.04204.x.
|
[8] |
Antiga E, Caproni M. The diagnosis and treatment of dermatitis herpetiformis[J]. Clin Cosmet Investig Dermatol, 2015,8:257⁃265. doi: 10.2147/CCID.S69127.
|
[9] |
姜玉衡. 金霉素治疗疱疹样皮炎一例报告[J]. 山东医刊, 1958,(08):29.
|
[10] |
林燕, 杨宝琦, 潘付堂, 等. 疱疹样皮炎1例[J]. 中国麻风皮肤病杂志, 2008,24(11):903. doi: 10.3969/j.issn.1009⁃1157.2008. 11.020.
|
[11] |
林燕, 周桂芝, 张福仁. 间接免疫荧光检测抗肌内膜抗体确诊疱疹样皮炎[J]. 中国麻风皮肤病杂志, 2009,25(6):447⁃449. doi: 10.3969/j.issn.1009⁃1157.2009.06.017.
|
[12] |
林燕, 周桂芝, 卢宪梅, 等. 疱疹样皮炎15例临床及病理学分析[J]. 临床皮肤科杂志, 2012,41(1):3⁃6. doi: 10.3969/j.issn. 1000⁃4963.2012.01.002.
|
[13] |
郑婷, 张迪展, 周桂芝, 等. 局部外用曲安奈德乳膏治愈疱疹样皮炎1例[J]. 中国麻风皮肤病杂志, 2015,(11):699⁃700.
|
[14] |
Sun Y, Lin Y, Yang B, et al. The HLA Alleles B*0801 and DRB1*0301 are associated with dermatitis herpetiformis in a Chinese population[J]. J Invest Dermatol, 2016,136(2):530⁃532. doi: 10.1016/j.jid.2015.10.057.
|
[15] |
Wang Y, Yang B, Zhou G, et al. Two cases of dermatitis herpetiformis successfully treated with tetracycline and niacinamide[J]. Acta Dermatovenerol Croat, 2018,26(3):273⁃275.
|
[16] |
Weng MW, Qiu BS, Kang KF. An analysis of 24 patients with IgA deposition at the BMZ[J]. J Dermatol, 1993,20(5):276⁃278.
|
[17] |
周曙霞,翁孟武,施守义. 局限性疱疹样皮炎1例[J]. 临床皮肤科杂志, 1994,(06):345.
|
[18] |
刘喜福, 王桂琴, 孙宝符, 等. 大疱性皮肤病26例临床、病理及免疫病理特点对照分析[J]. 白求恩医科大学学报, 1994,(01):61⁃62.
|
[19] |
翁孟武, 苏伟, 徐明, 等. 78例可疑疱疹样皮炎病例分析[J]. 中华皮肤科杂志, 1996,29(4):226⁃228.
|
[20] |
姜祎群, 曾学思, 李岷. 疱疹样皮炎1例[J]. 包头医学院学报, 1998,14(3):68. doi: 10.16833/j.cnki.jbmc.1998.03.050.
|
[21] |
姜薇, 吴健波, 雷鹏程. 疱疹样皮炎与大疱性类天疱疮混合型合并糖尿病1例[J]. 中国皮肤性病学杂志, 1999:43⁃44.
|
[22] |
李福秋, 姚煦, 金学洙, 等. 甲基强的松龙冲击疗法治疗重症疱疹样皮炎2例[J]. 中国乡村医生, 2001,17(8):42⁃43.
|
[23] |
陈柳青, 陈红英, 姜一化, 等. 疱疹样皮炎一例[J]. 中华皮肤科杂志, 2008,(01):60⁃61.
|
[24] |
张良. 疱疹样皮炎1例[J]. 中国麻风皮肤病杂志, 2012,28(11):811⁃812.
|
[25] |
夏登梅, 郭生红, Sanjaya Shakya, 等. 表现为环形红斑水疱的疱疹样皮炎1例[J]. 中国皮肤性病学杂志, 2013,27(7):706⁃708.
|
[26] |
郭生红, Sanjaya Shakya, 贾玲, 等. 疱疹样皮炎1例[J]. 临床皮肤科杂志, 2013,42(09):551⁃552.
|
[27] |
彭星, 田歆, 刘玉梅. 疱疹样皮炎1例[J]. 皮肤性病诊疗学杂志, 2014,21(4):324⁃325. doi: 10.3969/j.issn.1674⁃8468.2014.04. 019.
|
[28] |
Mansikka E, Salmi T, Kaukinen K, et al. Diagnostic delay in dermatitis herpetiformis in a high⁃prevalence area[J]. Acta Derm Venereol, 2018,98(2):195⁃199. doi: 10.2340/00015555⁃2818.
|
[29] |
Jakes AD, Bradley S, Donlevy L. Dermatitis herpetiformis[J]. BMJ, 2014,348:g2557. doi: 10.1136/bmj.g2557.
|
[30] |
West J, Fleming KM, Tata LJ, et al. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population⁃based study[J]. Am J Gastroenterol, 2014,109(5):757⁃768. doi: 10.1038/ajg.2014.55.
|
[31] |
Antiga E, Maglie R, Quintarelli L, et al. Dermatitis herpetiformis: novel perspectives[J]. Front Immunol, 2019,10:1290. doi: 10. 3389/fimmu.2019.01290.
|
[32] |
Shibahara M, Nanko H, Shimizu M, et al. Dermatitis herpetiformis in Japan: an update[J]. Dermatology, 2002,204(1):37⁃42. doi: 10.1159/000051808.
|
[33] |
Spurkland A, Ingvarsson G, Falk ES, et al. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA⁃DQ (alpha 1*0501, beta 1*02) or the HLA⁃DQ (alpha 1*03, beta 1*0302) heterodimers[J]. Tissue Antigens, 1997,49(1):29⁃34. doi: 10.1111/j.1399⁃0039.1997.tb02706.x.
|
[34] |
Reunala T, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a common extraintestinal manifestation of coeliac disease[J]. Nutrients, 2018,10(5): 602. doi: 10.3390/nu10050602.
|
[35] |
Collin P, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease[J]. Ann Med, 2017,49(1):23⁃31. doi: 10.1080/07853890.2016.1222450.
|
[36] |
Cardones AR, Hall RP 3rd. Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation[J]. Dermatol Clin, 2011,29(3):469⁃477. doi: 10.1016/j.det.2011.03.005.
|
[37] |
Fry L. The falling incidence and prevalence of dermatitis herpetiformis[J]. Br J Dermatol, 2011,165(2):229. doi: 10.1111/j.1365⁃2133.2011.10460.x.
|
[38] |
Mansikka E, Hervonen K, Salmi TT, et al. The decreasing prevalence of severe villous atrophy in dermatitis herpetiformis: a 45⁃year experience in 393 patients[J]. J Clin Gastroenterol, 2017,51(3):235⁃239. doi: 10.1097/MCG.0000000000000533.
|
[39] |
Bevans SL, Sami N. Dapsone and sulfasalazine combination therapy in dermatitis herpetiformis[J]. Int J Dermatol, 2017,56(5):e90⁃90e92. doi: 10.1111/ijd.13542.
|
[40] |
Abdelmaksoud A. Dermatitis herpetiformis (Duhring's disease): a therapeutic challenge[J]. Int J Dermatol, 2017,56(10):e192⁃192e193. doi: 10.1111/ijd.13641.
|
[41] |
Albers LN, Zone JJ, Stoff BK, et al. Rituximab treatment for recalcitrant dermatitis herpetiformis[J]. JAMA Dermatol, 2017,153(3):315⁃318. doi: 10.1001/jamadermatol.2016.4676.
|